The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat

Shock

Volumn 26, Issue 2, 2006, Pages 154-161

  Sivarajah, A ^a   McDonald, M C ^a   Thiemermann, C ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

5 hydroxydecanoate; Cystathionine lyase; DL propargylglycine; Left anterior descending coronary artery; Mitochondrial ATP sensitive K+ channels; Sodium hydrosulfide

Indexed keywords

5 HYDROXYDECANOIC ACID; CYSTATHIONINE GAMMA LYASE; ENDOTOXIN; HYDROGEN SULFIDE; NITROBLUE TETRAZOLIUM; PROPARGYLGLYCINE; SODIUM HYDROSULFIDE; SULFIDE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; RAT; REPERFUSION INJURY; STAINING;

ALKYNES; ANIMALS; CARDIOTONIC AGENTS; CYSTATHIONINE GAMMA-LYASE; DECANOIC ACIDS; ENDOTOXINS; ENZYME INHIBITORS; GLYCINE; HYDROGEN SULFIDE; HYDROXY ACIDS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MITOCHONDRIA; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, WISTAR; SULFIDES;

EID: 33746777809     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000225722.56681.64     Document Type: Article

References (31)

1. Moore PK, Bhatia M, Moochhala S: Hydrogen sulfide: from the smell of the past to the mediator of the future? Trends Pharmacol Sci 24:609-611, 2003.
2. Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y, Du J, Tang C: Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 318:756-763, 2004.
3. Cheng Y, Ndisang JF, Tang G, Cao K, Wang R: Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 287:H2316-H2323, 2004.
4. Zhao W, Zhang J, Lu Y, Wang R: The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 20:6008-6016, 2001.
5. Mok YY, Atan MS, Yoke PC, Zhong JW, Bhatia M, Moochhala S, Moore PK: Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol 143:881-889, 2004.
6. Collin M, Anuar FB, Murch O, Bhatia M, Moore PK, Thiemermann C: Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br J Pharmacol 146:498-505, 2005.
7. Chunyu Z, Junbao D, Dingfang B, Hui Y, Xiuying T, Chaoshu T: The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 302:810-816, 2003.
8. Geng B, Yang J, Qi Y, Zhao J, Pang Y, Du J, Tang C: H2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 313:362-368, 2004.
9. Zunnunov ZR: Efficacy and safety of hydrogen sulfide balneotherapy in ischemic heart disease the arid zone. Ter Arkh 76:15-18, 2004.
10. Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S, Moore PK: Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 316:670-678, 2006.
11. Das B, Sarkar C: Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model? Life Sci 77:1226-1248, 2005.
12. + channels. Possible mechanism of cardioprotection. Circ Res 81:1072-1082, 1997.
13. Hide EJ, Piper J, Thiemermann C: Endothelin-1 - induced reduction of myocardial infarct size by activation of ATP-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion. Br J Pharmacol 116:2597-2602, 1995.
14. Hide EJ, Thiemermann C: Limitation of myocardial infarct size in the rabbit by ischaemic preconditioning is abolished by sodium 5-hydroxydecanoate. Cardiovasc Res 31:941-946, 1996.
15. Carroll R, Yellon DM: Delayed cardioprotection in a human cardiomyocyte-derived cell line: the role of adenosine, p38MAP kinase and mitochondrial KATP. Basic Res Cardiol 95:243-249, 2000.
16. Downey JM, Cohen MV: Do mitochondrial K(ATP) channels serve as triggers rather than end-effectors of ischemic preconditioning's protection? Basic Res Cardiol 95:272-274, 2000.
17. Hassouna A, Matata BM, Galinanes M: PKC-epsilon is upstream and PKC-alpha is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium. Am J Physiol Cell Physiol 287:C1418-C1425, 2004.
18. Pain T, Yang XM, Critz SD, Yue Y, Nakano A, Liu GS, Heusch G, Cohen MV, Downey JM: Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res 87:460-466, 2000.
19. Das B, Sarkar C: Mitochondrial K ATP channel activation is important in the antiarrhythmic and cardioprotective effects of non-hypotensive doses of nicorandil and cromakalim during ischemia/reperfusion: a study in an intact anesthetized rabbit model. Pharmacol Res 47:447-461, 2003.
20. Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, Chatterjee PK, Thiemermann C: Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J 16:1027-1040, 2002.
21. Baller D, Zipfel J, Hellige G: Usefulness and limitations of myocardial oxygen consumption indices. Clin Cardiol 3:212-213, 1980.
22. Nachlas MM, Shnitka TK: Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity. Am J Pathol 42:379-405, 1963.
23. Uren JR, Ragin R, Chaykovsky M: Modulation of cysteine metabolism in mice-effects of propargylglycine and L-cyst(e)ine-degrading enzymes. Biochem Pharmacol 27:2807-2814, 1978.
24. Jiang HL, Wu HC, Li ZL, Geng B, Tang CS: Changes of the new gaseous transmitter H2S in patients with coronary heart disease. Di Yi Jun Yi Da Xue Xue Bao 25:951-954, 2005.
25. Distrutti E, Sediari L, Mencarelli A, Renga A, Orlandi S, Antonelli E, Roviezzo F, Morelli A, Wallace JL, Cirino G, et al: Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. J Pharmacol Exp Ther 316:325-335, 2006.
26. + channel in the mitochondrial inner membrane. Nature 352:244-247, 1991.
27. + channel from rat liver and beef heart mitochondria. J Biol Chem 267:26062-26069, 1992.
28. Grover GJ, Garlid KD: ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 32:677-695, 2000.
29. Liu Y, Sato T, O'Rourke B, Marban E: Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97:2463-2469, 1998.
30. Brown JM, Grosso MA, Terada LS, Whitman GJ, Banerjee A, White CW, Harken AH, Repine JE: Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc Natl Acad Sci U S A 86:2516-2520, 1989.
31. Zacharowski K, Frank S, Otto M, Chatterjee PK, Cuzzocrea S, Hafner G, Pfeilschifter J, Thiemermann C: Lipoteichoic acid induces delayed protection in the rat heart: a comparison with endotoxin. Arterioscler Thromb Vasc Biol 20:1521-1528, 2000.